Strata Critical Medical (SRTA) reported $197M in revenue for fiscal 2025, +34.3% year on year. That ranks #2667 by revenue among 2853 SEC filers and #286 in Healthcare. Net income was $41.3M, a net margin of 21.0%. Revenue has grown 36.0% a year on average since 2019 ($31.2M then). The fiscal 2025 balance sheet shows $325M in total assets, $31.0M in cash and $0 in long-term debt.
Key figures
| Key figures | FY2025 | YoY | Source |
|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $197M | +34.3% | FY20252025-12-31 |
| Gross profitGrossProfit | $41.1M | +39.0% | FY20252025-12-31 |
| Operating incomeOperatingIncomeLoss | −$22.4M | +$172,000 | FY20252025-12-31 |
| Net incomeNetIncomeLoss | $41.3M | +$68.7M | FY20252025-12-31 |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | −$48.9M | −$46.4M | FY20252025-12-31 |
| Capital expenditurePaymentsToAcquirePropertyPlantAndEquipment | $9.6M | −68.9% | FY20252025-12-31 |
| Total assetsAssets | $325M | +26.8% | FY20252025-12-31 |
| Shareholders' equityStockholdersEquity | $279M | +25.7% | FY20252025-12-31 |
| CashCashAndCashEquivalentsAtCarryingValue | $31.0M | +68.5% | FY20252025-12-31 |
| Long-term debtLongTermDebt | $0 | — | FY20222022-12-31 |
Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Reported since the last full year
Three-month figures this company has filed since FY2025. A quarter is not comparable with a full year, and these figures are used nowhere else on the site: not in any ranking, not in comparisons, not in the download.
| Quarter | Revenue | Net income | Source |
|---|---|---|---|
| Q1 20262026-03-31 | $67.4M | $2.2M | Open → |
| Q2 20262026-06-30 | $72.5M | −$10.5M | Open → |
Only periods that end on a calendar quarter appear here. A company whose fiscal year ends in June files on a different calendar, so it has no row.
Profile
- Legal name
- Strata Critical Medical, Inc.
- Ticker
- SRTA
- Exchange
- Nasdaq
- SIC classification
- Services-Health Services (8000)
- Fiscal year end
- 12-31
- CIK
- 0001779128
Filings
- 10-QAug 4, 2026Open filing →
- 10-QMay 6, 2026Open filing →
- 10-KMar 3, 2026Open filing →
Similar in size, same sector
| Company | Revenue | Net income |
|---|---|---|
| Canopy GrowthCGC | $204M | −$189M |
| Si-BoneSIBN | $201M | −$18.9M |
| ValnevaVALN | $197M | −$130M |
| Strata Critical MedicalSRTA | $197M | $41.3M |
| LifemdLFMD | $194M | −$11.2M |
| Lakeland IndustriesLAKE | $193M | −$25.3M |
| BioteBTMD | $192M | $27.0M |
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Strata Critical Medical — Key figures |url=https://companiesranked.com/en/company/strata-critical-medical |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Strata Critical Medical — Key figures. CompaniesRanked. https://companiesranked.com/en/company/strata-critical-medicalBibTeX
@misc{companiesranked-en-company-strata-critical-medical-2026,
author = {{CompaniesRanked}},
title = {{Strata Critical Medical — Key figures}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/strata-critical-medical}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001628280-26-013628 · March 3, 2026
{{cite web |title=Strata Critical Medical — Key figures — 10-K (0001628280-26-013628) |url=https://www.sec.gov/Archives/edgar/data/1779128/000162828026013628/blde-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-03-03}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.